Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China · Delayed Price · Currency is CNY 12.92
+0.07 (0.54%)
Jul 3, 2026, 3:04 PM CST
SHE:002675 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHE:002675 stock has a consensus rating of "Buy" and an average price target of ¥18.00. The average 1-year stock price forecast is 39.32% higher than the current stock price, while the lowest is ¥14.00 (+8.36%) and the highest is ¥22.00 (+70.28%).
Price Target: ¥18.00 (+39.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:002675 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 2 | 3 | 3 |
Financial Forecast
Revenue This Year
2.97B
from 2.74B
Increased by 8.21%
Revenue Next Year
3.30B
from 2.97B
Increased by 11.34%
EPS This Year
0.41
from 0.22
Increased by 88.25%
EPS Next Year
0.57
from 0.41
Increased by 39.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.1B | ||
| Avg | 3.0B | ||
| Low | 2.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.9% | ||
| Avg | 8.2% | ||
| Low | 4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.41 | ||
| Avg | 0.41 | ||
| Low | 0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 88.2% | ||
| Avg | 88.2% | ||
| Low | 88.2% |